Adage Capital Partners Gp, L.L.C. Cabaletta Bio, Inc. Transaction History
Adage Capital Partners Gp, L.L.C.
- $56.4 Billion
- Q2 2025
A detailed history of Adage Capital Partners Gp, L.L.C. transactions in Cabaletta Bio, Inc. stock. As of the latest transaction made, Adage Capital Partners Gp, L.L.C. holds 8,829,758 shares of CABA stock, worth $11.7 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
8,829,758
Previous 3,634,473
142.94%
Holding current value
$11.7 Million
Previous $5.05 Million
165.71%
% of portfolio
0.02%
Previous 0.01%
Shares
11 transactions
Others Institutions Holding CABA
# of Institutions
93Shares Held
77MCall Options Held
406KPut Options Held
90.9K-
Bain Capital Life Sciences Investors, LLC Boston, MA9.68MShares$12.9 Million4.41% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD6.79MShares$9.04 Million0.01% of portfolio
-
Jennison Associates LLC6.02MShares$8.01 Million0.01% of portfolio
-
Cormorant Asset Management, LP Boston, MA5MShares$6.65 Million0.77% of portfolio
-
Alyeska Investment Group, L.P. Chicago, IL4.8MShares$6.38 Million0.03% of portfolio
About Cabaletta Bio, Inc.
- Ticker CABA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,014,000
- Market Cap $38.6M
- Description
- Cabaletta Bio, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes chimeric autoantibody receptor (CAAR) T cells that are designed to selectively bind and eliminate B cells, which produce di...